2026 Scott C. Kogan: Molecular Biology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Molecular Biology	61	1884	1693	939	829	193	18182

Overview

Scott C. Kogan is affiliated with the University of California, San Francisco in the United States. Their research spans primarily across the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with significant work in molecular biology, public health, pediatrics, oncology, and hematology.

The scientist has contributed extensively to several main research topics, including:

Acute Lymphoblastic Leukemia research
Childhood Cancer Survivors' Quality of Life
Acute Myeloid Leukemia Research
Cytokine Signaling Pathways and Interactions
PI3K/AKT/mTOR signaling in cancer
Immune Cell Function and Interaction
Chronic Lymphocytic Leukemia Research

Frequent publication venues for their work include:

Blood
Cancer Epidemiology Biomarkers & Prevention
Haematologica
American Journal of Epidemiology
Leukemia

They have collaborated often with several researchers, among the most frequent co-authors are:

Joseph L. Wiemels
Catherine Metayer
Adam J. de Smith
Kevin Shannon
Mi Zhou

Some of their recent papers are:

RASA2 ablation in T cells boosts antigen sensitivity and long-term function, 2022, Nature
Trends in Acute Lymphoblastic Leukemia Incidence in the United States by Race/Ethnicity From 2000 to 2016, 2020, American Journal of Epidemiology
Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia, 2020, Leukemia
Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice, 2020, Blood
KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice, 2020, JCI Insight

Best Publications

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

Johannes Zuber;Junwei Shi;Junwei Shi;Eric Wang;Amy R. Rappaport;Amy R. Rappaport

2080
Citations
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.

Hans-Guido Wendel;Elisa de Stanchina;Jordan S. Fridman;Jordan S. Fridman;Abba Malina

1207
Citations
An Improved Method for Prenatal Diagnosis of Genetic Diseases by Analysis of Amplified DNA Sequences: Application to Hemophilia A

Scott C. Kogan;Marie Doherty;Jane Gitschier

1198
Citations
Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity

Yuchen Chien;Claudio Scuoppo;Xiaowo Wang;Xueping Fang

952
Citations
A PMLRARα transgene initiates murine acute promyelocytic leukemia

Diane Brown;Scott Kogan;Eric Lagasse;Irving Weissman

591
Citations
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.

Scott C. Kogan;Jerrold M. Ward;Miriam R. Anver;Jules J. Berman

481
Citations
Retinoic Acid and Arsenic Synergize to Eradicate Leukemic Cells in a Mouse Model of Acute Promyelocytic Leukemia

Valérie Lallemand-Breitenbach;Marie-Claude Guillemin;Anne Janin;Marie-Thérèse Daniel

444
Citations
Inhibition of apoptosis by the retinoblastoma gene product.

Unknown

412
Citations
Bethesda proposals for classification of lymphoid neoplasms in mice

Herbert C. Morse;Miriam R. Anver;Torgny N. Fredrickson;Diana C. Haines

382
Citations
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder.

Benjamin S. Braun;David A. Tuveson;Namie Kong;Doan T. Le

355
Citations
A rapid and scalable system for studying gene function in mice using conditional RNA interference.

Prem K Premsrirut;Prem K Premsrirut;Lukas E Dow;Sang Yong Kim;Matthew Camiolo;Matthew Camiolo

353
Citations
mTORC1 promotes survival through translational control of Mcl-1

John R. Mills;Yoshitaka Hippo;Francis Robert;Samuel M. H. Chen

327
Citations
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.

Chong Chen;Yu KiKi Liu;Amy R Rappaport;Thomas Kitzing

322
Citations
Mouse models of human AML accurately predict chemotherapy response

Johannes Zuber;Ina Radtke;Timothy S. Pardee;Zhen Zhao

321
Citations
An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance

Johannes Zuber;Amy R. Rappaport;Weijun Luo;Eric Wang

300
Citations
Functional dissection and sequence of yeast HAP1 activator

Karl Pfeifer;Kwang-Soo Kim;Scott Kogan;Leonard Guarente

296
Citations
New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors.

E. Camilla Forsberg;Thomas Serwold;Scott Kogan;Irving L. Weissman

279
Citations
Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders

John M. Joslin;Anthony A. Fernald;Thelma R. Tennant;Elizabeth M. Davis

266
Citations
Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder.

Doan T. Le;Namie Kong;Yuan Zhu;Jennifer O. Lauchle

253
Citations
Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family.

Patrick Viatour;Tim C. Somervaille;Shivkumar Venkatasubrahmanyam;Scott Kogan

229
Citations

Frequent Co-Authors

Kevin Shannon University of California, San Francisco

Scott W. Lowe Memorial Sloan Kettering Cancer Center

Michelle M. Le Beau University of Chicago

Johannes Zuber Research Institute of Molecular Pathology

Irving L. Weissman Stanford University

Joseph L. Wiemels University of Southern California

Christine Chomienne Université Paris Cité

Jane Gitschier University of California, San Francisco

Anne Janin Université Paris Cité

David A. Largaespada University of Minnesota

External Links

Personal website of Scott C. Kogan

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring Molecular Biology often raises questions about flexible career options and pathways. Many related fields now offer convenient online degree programs, making it easier to balance study, work, and other commitments.

If you’re interested in science communication or information management, consider the cost of mlis degree us—a pathway into libraries, research institutions, and information science. For those fascinated by healthcare and communication, speech-language pathology is another in-demand field. Accredited programs are essential; check out asha approved slp programs for online options that meet national standards.

Individuals with a background in molecular or biological sciences can transition into clinical speech-language roles through slp bridge programs, which are designed specifically for non-SLP majors. Additionally, if you’re considering a shift to nursing, accelerated bsn programs for non nurses enable a rapid transition into nursing careers—even without prior nursing experience.

Each of these online pathways offers flexibility, affordability, and diverse career prospects, making them excellent alternatives or complements to molecular biology training.